382
Views
77
CrossRef citations to date
0
Altmetric
Reviews

Secondary and tertiary sulfonamides: a patent review (2008 – 2012)

, &
Pages 203-213 | Published online: 14 Nov 2012

Bibliography

  • Carta F, Scozzafava A, Supuran CT. Sulfonamides: a patent review (2008 – 2012). Expert Opin Ther Pat 2012;22(7):747-58
  • Rishton GM, Retz DM, Tempest PA, Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease. J Med Chem 2000;43:2297-9
  • Hannam JC, Harrison T, Madin A, Sparey TJ. Sulphonamides for control of the beta-amyloid production. US0186147; 2004
  • Kreft AF, Resnick L, Mayer SC, Diamantidis G Fluoro and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof. WO092155; 2004
  • Neitzel M. N-Substitued heterocyclic sulfonamides. WO078753; 2006
  • Neitzel M, Dappen MS, Marugg J. N-Substitued benzenesulfonamides. US0212920; 2011
  • Anglada L, Palomer A, Princep M, Guglietta A. N-[3-3-Substituted-pyrazolo[1,5-a] pyrimidin-7-yl]sulfonamides, and compositions and methods related thereto. WO014597; 2005
  • Wood MR, Kim J, Mcwherter M, CGRP Receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups. WO127584; 2008
  • Olesen J, Diener H-C, Husstedt IW, Calcitonin gene–related peptide receptor antagonist bibn 4096 bs for the acute treatment of migraine. New Engl J Med 2004;350:1104-10
  • Kenneth A, Petersen KE, Lisbeth H, BIBN4096BS antagonizes human-calcitonin gene related peptide–induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 2005;77:202-13
  • You L-C, Hansson P, Lundeberg S, Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation. Eur J Pharm 1998;347:275-82
  • Bennet AD, Chastain KM, Hulsebosch CE, Alleviation of mechanical and thermal allodynia by CGRP8-37 in a rodent model of chronic central pain. Pain 2000;86:163-75
  • Salmon AM, Imad Damaj M, Marubio LM, Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in CGRP-deficient mice. Nature Neurosci 2001;4:357-8
  • Beer S, Weighardt H, Emmanuilidis K, Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 2002;30:1794-8
  • Hoffmann P, Mazurkiewicz J, Holtmann G, Capsaicin-sensitive nerve fibres induce epithelial cell proliferation, inflammatory cell immigration and transforming growth factor-alpha expression in the rat colonic mucosa in vivo. Scand J Gastroenterol 2002;37:414-22
  • Ohki-Hamazaki H, Watase H, Yamamoto K, Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 1997;390:165-9
  • Ward TJ, Crossley R, Slater MJ Imidazopyridine derivatives as BRS-3 antagonists. WO080390; 2005
  • Barker E, Crossley R Imidazopyridine derivatives which interact with the G-protein coupled receptor family. WO056532; 2005
  • Weber D, Kessler H, Berger C, Non-peptidic BRS-3 agonists. WO104196; 2003
  • Baker RK, Chang LL, Chioda M, Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators. WO073311; 2008
  • Buschmann HH, Quintana Ruiz J-R, Arjona JC, Xavier CS. Benzimidazole-2- & pyrido[d]imidazole-2-sulphonamide derivatives for the treatment of disorders mediated via 5-HT6 receptors, eg those related to food intake. GB2435825A; 2007
  • Diaz FJL. Heterocyclic substituted sulphonamides for the treatment of cognitive of food ingestion related disorders. WO092665; 2008
  • Petry S, Baringhaus K-H, Tennagels N, . Novel bicyclic inhibitor of hormone sensitive lipase. WO035550; 2004
  • Ebdrup S, Hansen HC, Vedsø P, Compounds and use therof for decreasing activity of hormone sensitive lipase. WO051842; 2003
  • Schoenafinger K, Petry S, Mueller G, Baringhaus K-H. Substituted N-aminomethylene sulfonamides, production and use therof as medicaments. WO0069851; 2008
  • Martinborough E, Zimmermann N, Neubert T, Hampton TL. Pyridyl sulfonamides as modulators of ion channels. WO039328; 2009
  • Beaudoin S, Johnson MS, Marron BE, Suto MJ. Sodium channels inhibitors. WO012241; 2009
  • Fulp AB, Johnson MS, Markworth CJ. Sodium channels inhibitors. WO012242; 2009
  • Wang X, Fulp A, Marron B. Inhibitors of ion channels. US0234343; 2010
  • Armstrong HM, Chang LL, Guthikonda RN. Substituted sulfonamides. WO027837; 2005
  • Chambers SM, Jones P, Szekeres HJ N-(3(4-Substituted-1-piperiding1)-1-phenylpropyl)-substituted sulfonamide as NK-3 receptor antagonists. US0117847; 2007
  • Bai D, Weizhou C, Yunxin B N-substituted benzyl or phenyl aromatic sulfonamides compounds for the use thereof. US6605635; 2003
  • Morgan BP, Malik F, Kraynack EA. Heterocyclic sulfonamides. US0088779; 2012
  • Dashyant D, Knight SD, Jin J, . Pyrrolidine sulfonamides. US0197345; 2005
  • Murugesan N, Ewing W, Gu Z, Substituted biphenyl sixazole sulfonamides as dual angiotensin endothelin receptor antagonists. WO109456; 2007
  • Delarge J, Dogne J-M, Masereel B Benzenic sulphonamide derivatives and their uses. WO42004; 2000
  • Blacker AJ. N-[-Hydroxy-3-hydroxycarbonylamino)-3-methyl]-N-methyl-sulphonamide derivatives via N-[2-oxo-3-(3-hydroxycarbonylamino)-3-methyl]-N-methyl-imine skeleton. GB2452952; 2009
  • Roberts JC, Toczko JF, Preparation of chemical compounds. WO000249; 2005
  • McLean Ed W, Miller JF. HIV protease inhibitors. WO104646; 2006
  • Urban A, Brohm D, Birkmann A, Substituted N-benzyl-N-phenylbenzenesulphonamides for treating viral infections. WO110171; 2007
  • Simmen KA, VanAcker KLA, Wigerinck PTBP, HCV Inhibiting sulfonamides. US0234288; 2008
  • Surleraux DLNG, Wigerinck PTBP, Getman D, Broadspectrum 2-(substituted amino)-benzothiazole sulfonamide HIV protease inhibitors. WO083657; 2002
  • Surleraux DLNG, Vendeville SMH, Verschueren WG, Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors. WO092595; 2002
  • Surleraux DLNG, Vendeville SMH, Verschueren WG, Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors. WO081478; 2002
  • Vendeville SMH, Verschueren WG, Tahri A, Broadspectrum heterocyclic substituted phenyl containing sulphonamide HIV protease inhibitors. WO053435; 2003
  • Surleraux DLNG, Wigernick PT, Voets MC, Small molecule entry inhibitors. US0203743; 2009
  • Surleraux DLNG, Vergouwen BJB, De Kock HA. Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors. EP50173; 2003
  • Ghilslain DLS, Surleraux DLNG, Wigernick PT, Getman PT Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors. US0203742; 2009
  • Bender W, Reefschläger J, Eckenberg P, Naphthyl substituted and anilide substituted sulfonamides. US6417181; 2002
  • Ungashe S, Pennel AMK, Punna S, Hetroarylsulfonamides and CCR2. EP2474532; 2012
  • Harrison R, Mete A, Teobald B, Walters I. Sulphonamide compounds that modulate chemokine receptor activity; CCR4. WO108692; 2004
  • Mete A, Teobald B. Sulphonamide compounds that modulate chemokine receptor activity; CCR4. WO108717; 2004
  • Cleva C, Page P, Schwarz M, Pirazino sulfonamidas sunstituidas. PT1871374E; 2006
  • Jones GP, Hardy D, Macritchie JA, Slater MJ. compound libraries of 2,3-substituted pyrazine derivatives capable of binfding to G-protein coupled receptors. WO058265; 2004
  • Ford R, Martin B, Thompson T, Adamantyl derivatives as P2X7 receptor antagonists. WO025783; 2006
  • Owen DA, Watson RJ, Allen DR, Hydroxamate sulfonamides as CD23 shedding inhibitors. US0276507; 2006
  • Owen DA, Watson RJ, Allen DR, Hydroxamate sulfonamides as CD23 shedding inhibitors. WO113312; 2004
  • Sugue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog. Retin Eye Res 2000;19(1):87-112
  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Rev Drug Disc 2008;7:168-81
  • Supuran C, Benedini F, Biondi S, Ongini E. Nitrate esters of carbonic anhydrase inhibitors. WO071421; 2008
  • Cioffi GA, van Buskirk EM. Microvasculature of the anterior optic nerve. Surv Ophtalmol 1994;38:S107-16
  • Burk MR. Novel sulfonamides. US0167331; 2008
  • Safar P, Walser A, Shimshock SJ. Substituted sulfonamides and ureas as useful for inhibiting kinase activity. US0208008; 2007
  • Ralston HS, Iain R, Aymed IIM, Van'T Hof RJ. Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions. US0119555; 2008
  • Welmaker GS, Wilson MA, Moore WJ, Indole sulfonamides as SFRP-1 modulators. WO060998; 2008
  • Bodine PV, Zhao W, Kharode YP, The wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004;18(5):1222-12
  • Reddy PE, Reddy RMV. Heteroarylsulfones and sulfonamides and therapeutic uses thereof. WO123077; 2005
  • Garcia G, Daram P, Froesch B, Sulfonamides and their use as medicaments. US0249135; 2010
  • Maderna A, Vernier JM, Barawkar D, N-(Arylamino)-sulfonamide inibitors of MEK. WO014011; 2007
  • Koh Y-H, Hong Z, Vernier JM, Pyridone sulfonamides and piridone sulamides as MEK inhibitors. WO121481; 2007
  • Vernier JM, Rowlings CE, Rardet JL, Derivatives of N-(arylamino)-sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods of preparing the same. WO018233; 2009
  • Xiao D, Zhu L, Wang S, Novel 6-arylamino pyridone sulfonamides and 6 arylamino pyrazinone sulfonamides as MEK inhibitors. WO145197; 2010
  • Liou JP, Chang JY, Hsieh HP. Indoline-sulfonamides compounds. US0058386; 2008
  • Grammenos W, Blettner C, Muller B, 4-Pyridinylmethylsulfonamide derivatives as fungicidal plant protection agents. US0221177; 2008
  • Grammenos W, Glaettli A, Lohmann JK, Muller B, Vrrettou M Substituted pyridin-4-ylmethyl sulfonamides. US0130283; 2011
  • Hacker E, Waldraff C, Schreiber D, Herbicidal combination. WO053061; 2009
  • Hacker E, Bieringer H, Lorenz K. Herbicidal compositions comprising N-[(4,6-dimethoxypyridin-2-yl)aminocarbonyl]-5-sulphonamidomethyl-2-alkoxycarbonylbenzene sulphonamides. US6221809; 2001
  • Ziemer F, Haaf K, Willms L, N-Acylsulphonamides, novel mixtures of herbicides and antidotes, and their use. US6235680; 2001
  • Gesing ERF, Drewes MW, Jansen JR, Substituted triazoloazine sulphonamides. US6297195; 2001
  • Dietz J, Grote T, Grammenos W, Substituted triazinylmethyl sulphonamides. US045974; 2011
  • Lohmann JK, Substituted heteroarylmethyl sulphonamides. WO9141292; 2009
  • Frackenpohl J, Heinemann I, Muller T, Aryl and Heterarylsulfonamides as active ingredients against abiotic plant stress. US230350; 2011
  • Castells Boliard J, Miguel Centeno BE, Pascual Gilabert M. N-substituted N-phenethyl sulphonamide libraries for the identification of biological and pharmacological activity. WO000994; 2011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.